Malignant Transformation of Ovarian Mature Cystic Teratoma: A Retrospective Analysis of 11 Cases from a Single Center

Ovaries are small, almond-shaped organs that sit deep within the pelvis, responsible for releasing eggs and producing hormones. Sometimes, these organs develop cysts, which are fluid-filled sacs. One specific type of cyst, known as a mature cystic teratoma, is a benign growth that contains fully formed tissues like hair, skin, teeth, or fat, all derived from the body's earliest embryonic cells. For most people, these growths remain harmless and are easily removed. However, in very rare instances, the mature, benign tissue inside these cysts can suddenly change, or transform, into a cancerous tumor. This shift is a dangerous event because it turns a manageable condition into a life-threatening one, yet doctors struggle to predict when or if it will happen. The challenge lies in the fact that the warning signs are often invisible; the cyst might look and feel exactly the same as a harmless one until it is too late.

A team of researchers at the Third Xiangya Hospital in China recently looked back at the medical records of eleven women who experienced this rare transformation. They wanted to understand what these patients had in common, how the doctors diagnosed the problem, and what treatments worked best. The study covered a period from 2015 to 2026 and focused on women whose ages ranged from 21 to 73, with an average age of 57. Most of the women had already gone through menopause. When these women first visited the hospital, they did not all have the same complaints. Some felt pain or swelling in their belly, while others could feel a hard lump when they touched their stomach. A few had no symptoms at all and were only found to have a mass during a routine checkup, and one woman noticed changes in her menstrual cycle. The tumors they carried were quite large, ranging from about 6 centimeters to over 21 centimeters in diameter, with an average size of 11 centimeters.

When the doctors examined the women using scans like CT or MRI, they saw that most of the tumors were not just simple fluid-filled bags. Nine of the eleven tumors appeared as a mix of solid and cystic parts, meaning they had both liquid and firm tissue inside. Only two looked like pure cysts. The researchers also tested the women's blood for various markers, which are substances that sometimes rise when cancer is present. They found that many women had high levels of certain markers, such as CA125 and CA19-9, but not all of them. In fact, some women had completely normal blood test results even though they had cancer. This finding is crucial because it means that a normal blood test cannot be used to rule out this disease. The doctors also looked for a virus called HPV, which is known to cause some cancers, but they found it in only one patient, suggesting that this virus is not the main cause for most of these cases.

Every woman in the study underwent surgery to remove the tumor. Some had a minimally invasive procedure using small incisions, while others required a larger open surgery. During the operation, the surgeons took a small piece of the tumor and had it analyzed immediately to see if it was cancer. This quick test helped them decide how much tissue to remove right then and there. For most patients, the surgery involved removing the affected ovary and fallopian tube, and in many cases, the uterus, other ovary, and surrounding tissue were also taken out to ensure no cancer cells were left behind. After the surgery, the final pathology report confirmed the type of cancer. In six cases, the cancer was a type called squamous cell carcinoma, which is similar to skin cancer. Three cases were a mix of glandular and squamous cells, and two cases were a rare type of tumor called strumal carcinoid.

The outcome of the treatment depended heavily on how far the cancer had spread before it was removed. The researchers used a standard staging system to measure this spread. Four women had the cancer confined to one ovary, and these patients did very well, with no signs of the disease returning for many years. One woman with a slightly more advanced stage also survived without recurrence. However, the women whose cancer had spread further into the abdomen or to other organs faced a much harder battle. Three of the women with advanced disease passed away within a few months of their surgery, while one woman with advanced disease was still alive at the thirty-month mark. The two women with the rare strumal carcinoid tumors, who both had early-stage disease, had excellent outcomes and did not need chemotherapy.

The researchers concluded that this rare transformation is incredibly difficult to spot before surgery because there are no specific symptoms or blood tests that always give the answer. However, they identified a clear pattern of risk. If a woman is older, has gone through menopause, and has a large tumor that is bigger than 10 centimeters and contains solid parts, she is at a higher risk for this transformation. The study suggests that doctors should be very careful with such patients. Even if blood tests look normal, the size and nature of the tumor should prompt immediate surgery. During the operation, a rapid analysis of the tissue is essential to guide the surgeon on how much to remove, preventing the need for a second surgery later. While there is no single cure that works for everyone, tailoring the treatment to the specific type of cancer and how far it has spread offers the best chance for survival, especially for those caught in the early stages.